Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6190]

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

Nivolumab further demonstrates increase in overall survival in NSCLC

Nivolumab further demonstrates increase in overall survival in NSCLC

Existing drug could treat aggressive brain cancer

Existing drug could treat aggressive brain cancer

Scientists discover hidden differences among cells that may help them evade drug therapy

Scientists discover hidden differences among cells that may help them evade drug therapy

Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer

Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer

Liquid biopsies reveal genetic alterations linked to cancer drug resistance

Liquid biopsies reveal genetic alterations linked to cancer drug resistance

Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy

Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy

Risks factors of oestrogen therapy among women with a hysterectomy determined

Risks factors of oestrogen therapy among women with a hysterectomy determined

The potential of antihistamines in causing the death of leukaemic stem cells

The potential of antihistamines in causing the death of leukaemic stem cells

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

More from ecancer